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Nocardiae (genus Nocardia) are aerobic, Gram-positive, mycolic 
acid-containing actinomycetes and characteristically form acid-
alcohol-fast branching filaments. They are saprophytes, but have been 
known to cause invasive and disseminated infections in humans and 
animals for >100 years.[1,2] Infections caused by N. otitidiscaviarum 
are rare (3%) compared with those caused by other Nocardia spp. 
Infection in humans was first reported in the mid-1960s and the 
first systemic infection in humans was reported in 1974,[3,4] when 
Nocardia sp. was diagnosed in the lungs of a 76-year-old man who 
had asthma since the age of 6 years. His asthma problem worsened 
owing to pulmonary nocardiosis or prolonged steroid therapy.[5]
The diagnosis of pulmonary nocardiosis based on clinical and 
radiological features is problematic, as these resemble other lung 
pathogens, including Mycobacterium tuberculosis. There is a dearth of 
knowledge in the epidemiological, clinical presentations, outcomes and 
laboratory information of nocardiosis, which challenge its importance 
as a threatening health risk.[2,6] This report aimed to identify a unique 
isolate that caused a severe illness in a female asthmatic patient.
Case report
We report the case of a 41-year-old woman with severe pneumonia. 
She had an 18-month history of bronchial asthma and underwent 
a cholecystectomy 5 years previously. On admission, the patient 
was suffering from bronchial asthma and severe pneumonia, with 
a productive cough (yellow sputum) of >3 months’ duration. She 
complained of high-grade fever and appeared ill, with dyspnoea and 
wheezing. Crepitations could be heard over the right lower zone of 
the chest. An electrocardiogram (ECG) indicated sinus tachycardia, 
abnormal rhythm and possible atrial enlargement. 
A computed tomography (CT) scan of the chest showed bilateral 
asymmetrical patchy air space disease, more evident on the right 
side. There was consolidation on the middle lobe and bilateral 
pleural effusion, but no cavities. These signs are suggestive of atypical 
pneumonia. 
Chest radiographs of the patient indicated consolidation on the 
right lower lobe, left lobular infiltration and right pleural effusion 
(Fig. 1).
Pleural aspirates were collected using ultrasound guidance. The 
pleural fluid appeared bloody, with a white blood cell count of 10 000/µL, 
comprising 80% neutrophils and 20% lymphocytes. The protein content 
was 3.09 g/dL and glucose was 168 mg/dL. A Ziehl-Neelsen-stained 
smear was made from the aspirate and from a sputum sample. The 
smear showed acid-fast branching filaments (Fig. 2) suggestive of 
Nocardia infection.
On admission the patient was administered cefuroxime and 
clarithromycin. The following day, after we received the laboratory 
report, the patient was administered sulfamethoxazole 3 tablets 
(160 mg) 3 times daily, and amikacin 500 mg and imipenem 500 mg 
intravenously. Ten days later the patient developed pancytopenia. 
The sulfamethoxazole and amikacin regimen was discontinued. 
The patient was administered ceftriaxone 2 g intravenously twice 
daily plus imipenem 500 mg intravenously and was given a blood 
transfusion. On receiving the results of the laboratory antimicrobial 
assay, we started the patient on ceftriaxone 2 g intravenously twice 
daily, amikacin 500 mg intravenously twice daily plus ciproflox-
acin 500 mg orally twice daily. Three days later she was progressing 
well, and no crepitations were detected. The patient recovered, but 
had a dry cough and crepitations for a while.
Growth of the causative agent was obtained from both sputum and 
pleural aspirate specimens on blood agar (BBL Microbiology Inc., 
USA) after 3 days under aerobic conditions at 30°C. Subsequently, 
the organism was sub-cultured for identification on other bacterio-
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logical media, including glucose malt 
extract, yeast extract agar, tryptic soya agar 
and Löwenstein-Jensen media. The morpho-
logical properties of the grown culture 
indicated an actinomycete-type organism 
with a chalky grey-white, rough, wrinkled 
appearance deeply embedded into agar 
(Fig. 3). Smears made from the culture 
revealed Gram-positive and partially acid-
fast branching filamentous organisms when 
stained with the modified Ziehl-Neelsen 
method. The filaments appeared as short 
chains of rods and coccobacillary elements, 
which are characteristic for organisms of the 
genus Nocardia.[1] The organism displayed 
in vitro sensitivity to amikacin, cefditoren, 
ciprofloxacin, meropenem and streptomycin, 
but resistance to azithromycin, erythromycin, 
ceftazidime, penicillin, rifampin, and sulfa-
methoxazole/trimethoprim (Fig. 3).
Six days later Acinetobacter spp. were iso-
lated from the sputum, which were found 
to be sensitive to only colistin, a clear mul-
tidrug-resistant nosocomial complication. 
The patient was then administered colistin 
intravenously and nebulised. She improved, 
sputum culture was negative, colistin was 
discontinued and she was discharged. 
16S rDNA nucleotide sequences data 
(1473 bp; Genbank (National Institutes of 
Health, USA) accession no. KX500116) were 
first analysed using the basic local align-
ment search tool (BLAST, USA) system[7] 
to determine a swift phylogenetic position. 
After designation of the isolate with Nocar­
dia spp. in the BLAST system, the sequences 
were analysed using Molecular Evolutionary 
Genetics Analysis version 6.0 (MEGA6) soft-
ware (Center for Evolutionary Medicine and 
Informatics, USA)[8] and compared with all 
known sequences of Nocardia spp. found in 
the GenBank database.[9] The isolate SD16 
was identical to that of N. otitidiscaviarum in 
the 16S rDNA gene phylogenetic tree (Fig. 4).
Our patient had signed an informed 
consent form, indicating her agreement to 
participate in the study.
Discussion
Pulmonary nocardiosis is diagnosed in a 
considerable number of patients who suffer 
from chronic lung diseases in African coun-
tries.[10] Previously, we noticed that Nocar­
dia spp. cause pulmonary infections in both 
immunocompetent and immunocompro-
mised patients.[11] Pulmonary nocardiosis 
is a rare opportunistic infection that pre-
dominantly affects immunocompromised 
patients. A high clinical suspicion is vital for 
an early diagnosis and appropriate treatment 
in such patients, who present with chest 
involvement or signs of chronic pneumonia.[12]
N. otitidiscaviarum is commonly resistant 
to beta-lactams, including most broad-spec-
trum cephalosporins, amoxicillin-clavulanic 
acid, and imipenem, but are usually sus-
ceptible to amikacin, fluoroquinolones, and 
sulfonamides.[6,9] The isolate showed in vitro 
anti biotic suscep ti bilities similar to those 
reported previously.[6] Our patient was treated 
empirically with trimethoprim-sulfamethox-
azole, but it was discontinued on receiving 
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Fig. 3. Growth of isolate SD16 on blood agar after 7 days under aerobic conditions. (A) The growth 
indicates actinomycete­type organisms with chalky grey­white, rough, wrinkled colonies, which are 
embedded into agar. (B) The antimicrobial assay shows clear sensitivity of the isolate to amikacin. The 
dark zone of inhibition is discernable around the amikacin­impregnated disk.
Fig. 1. Chest radiograph of the 41­year­old patient, showing right lower­lobe consolidation and left lobular 
infiltration. There is also right pleural effusion. (A) Anteroposterior view. (B) Posteroanterior view.
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Fig. 2. A Ziehl­Neelsen­stained smear, which was obtained from sputum of the 41­year­old female 
patient with pulmonary infection. The smear shows partially acid­fast branching filaments, which 
fragmented into short chains; notice the many inflammatory and granulomatous cells.
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the laboratory report. Complications and dif-
ficulties with regard to treatment seem similar 
to those in a previously reported pulmonary 
nocardiosis patient with asthma,[5] who was 
treated with a series of antimicrobials, includ-
ing sulfamethoxazole and trimethoprim, fol-
lowed by imipenem/cilastatin, amikacin and 
minocycline.[5]
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Fig. 4. A phylogenetic tree showing the relationship of Nocardia sp. strain SD16 (reverse and forward 
sequences) with the majority of related Nocardia spp. (bold bar). The tree was determined using the 
Neighbor­Joining method. All positions containing gaps and missing data were eliminated. Evolutionary 
analysis was performed using MEGA6 software.[8] The scale bar indicates 0.005 substitution per 
nucleotide position.
